STAT+: Novo Nordisk to buy Akero Therapeutics, picking up promising MASH drug
Novo Nordisk on Thursday said it would acquire Akero Therapeutics, the developer of a drug to treat the liver disease known as MASH, in a deal worth up to $5.2 billion. The acquisition values Akero at $54 per share, or a 16% premium to Wednesday’s closing price, equal to a market value of $4.7 billion. […]
How PepsiCo is riding the Ozempic wave with protein drinks
Americans have developed a near-insatiable craving for protein. That’s led large food manufacturers like PepsiCo to come up with new formulas that prominently feature the popular macronutrient. On Thursday, PepsiCo became the latest to make a more aggressive protein pitch to consumers. The soda and snacking giant unveiled a Starbucks coffee protein drink, a reformulated […]
Fitness coach warns that GLP-1 weight loss drugs aren’t for everyone, explains who they are really meant for
Weight loss might often feel like a uphill journey but not everyone who wants to get rid of those extra kilos should resort to GLP-1 drugs.
Ozempic-like medications may trigger false cancer signals on scans
A new study finds that GLP-1 weight-loss drugs such as Ozempic and Wegovy may alter PET-CT cancer scans, raising concerns about false positives and unnecessary treatment risks
Semaglutide, Tirzepatide Named First-Line Drugs for Obesity
New guidance from the European Association for the Study of Obesity says that semaglutide or tirzepatide should be first-line drugs for obesity and most related complications. Medscape Medical News
Amazon Installing Automated Medication Kiosks At Clinics
Amazon Pharmacy will begin offering prescription pickup kiosks at its One Medical clinics starting in Los Angeles this December, allowing patients to collect common medications like antibiotics and inhalers without waiting for delivery. Reuters reports: The kiosks will be the first in-person pick-up service offered by Amazon Pharmacy, which has been providing prescription services primarily […]
5 GLP-1 updates
GLP-1 medications, originally approved for diabetes, are rapidly expanding into new therapeutic territory — from cardiovascular to anti-inflammatory effects. Norma Keller, MD, chief of cardiology at NYC Health + Hospitals/Bellevue, recently told Becker’s prevention programs should embrace these therapies. “We need to become comfortable with them to understand their benefits, limitations and how they interact […]
Here’s Exactly How Much Protein to Eat if You’re on a GLP-1
It may take more than you think to prevent dangerous loss of muscle mass.
Open Enrollment for Medicare: Key Changes to Know About Your Plan
There may be fewer Medicare Advantage plans available in 2026, although the average premium is expected to decrease. Johner Images/Getty Images The Medicare open enrollment period begins on October 15 for older adults who wish to enroll in or change their current health insurance plans. There’s expected to be slightly fewer Medicare Advantage plans offered […]
Fractyl Health reports preclinical data on RJVA-002 for obesity
Fractyl Health Inc. has announced data on RJVA-002, a dual GIP/GLP-1 gene therapy candidate.